Unlock In-Depth Reporting.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eid
World Cup
Social Media
Elon Musk
Donald Trump
Artificial Intelligence
Natural Disasters
Soccer
Cricket
Drones
Instagram
Real Madrid
CNIO image

News from CNIO

We’ve assigned a rating of Unknown factuality to CNIO. You can read more about how we’ve determined CNIO’s credibility and reliability as a news source here: https://ground.news/rating-system.

Information about CNIO

Where is CNIO located?CNIO's WebsiteCNIO's Twitter

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top CNIO News

Chamberlain supports constituent’s pancreatic cancer petition
Scotland, United Kingdom · Scotland

Chamberlain supports constituent’s pancreatic cancer petition

100% Center coverage: 1 sources
Wendy Chamberlain, MP for North East Fife, has yesterday supported a petition organised by constituents urging the government to fund vital research into pancreatic cancer early detection.See the Story

Manuel Valiente, Awarded the Admirables 2025 Medical Journal Award

The researcher Manuel Valiente, head of the Brain Metastasis Group of the National Center for Oncological Research (CNIO), is one of the winners in the 5th edition of the Admirable Awards 2025, organized by Diario Médico y Correo Farmacéutico to recognize the trajectory and daily work of health professionals and researchers. Valiente has received the award in the category of research. The awards recognize 12 Spanish health professionals in the c…Madrid, Spain · MadridRead Article

Wnt/β-catenin/HNF4α feedback loop facilitates colorectal tumorigenesis and malignancy

Background: The Wnt/β-catenin signaling pathway is a central regulator of colorectal cancer (CRC) development, yet its downstream targets and mechanistic contributions to tumorigenesis remain poorly defined. Hepatocyte nuclear factor 4 alpha (HNF4α), a transcription factor pri...CancerSee the Story

Madrid, world pioneer in successfully treating a rare disease with CAR-T

For the first time in the world, Madrid's public health system has successfully treated a very rare autoimmune disease with CAR-T, a therapy for genetic modification of certain immune system cells that recognizes and destroys cancers. This new global medical milestone of health professionals in the Community of Madrid has been achieved in Hospital Universitario La Paz, with an 11-year-old girl suffering from a pathology called anti-MDA dermatomy…Madrid, Spain · MadridSee the Story

Why cells need brakes: Uncovering the role of MAD1 as a guardian against cancer

100% Right coverage: 1 sources
Have you ever imagined a car speeding down the road with no brakes? Scary, right? That is how cancer cells behave as they grow and divide uncontrollably. ...Cancer · ToledoSee the Story

Toxin produced by E. coli ‘could be driving bowel cancer rates in young people’

38% Left coverage: 60 sources
A toxin produced by E. coli may be driving rates of bowel cancer in young people, scientists have discovered. Experts believe the finding could help explain why rates of bowel cancer are rising among young people across the globe.Health · United KingdomSee the Story

Inherited genetic variants play crucial role in cancer development and behavior

100% Center coverage: 5 sources
A new multicenter study by researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with the National Cancer Institute-funded Clinical Proteomic Tumor Analysis Consortium (CPTAC) and colleagues around the world, has discovered that the genes we are born with-known as germline genetic variants-play a powerful, underappreciated role in how cancer develops and behaves.Artificial IntelligenceSee the Story

Guadalupe Sabio, the scientist who pursues the 'ozempic' of liver cancer: "We seek microproteins to use them as therapy"

100% Center coverage: 1 sources
The incidence of liver cancer in Spain is 6,856 cases per year. Of these, 5,334 in men and 1,522 in women. Not being one of the most prevalent tumors, the fifth being the most annual deaths caused by one of the worst lethalities. "95 per cent of the population suffering from it dies in less than three months," explains Guadalupe Sabio, a biochemist who researches from his laboratory at the National Cancer Research Center (CNIO) the relationship …Ozempic · MadridSee the Story

FDA Clears ZEISS INTRABEAM 700 for Intraoperative Radiation Therapy in Neuro-Oncology & Breast Cancer

The ZEISS INTRABEM 700 platform received 510(k) clearance from the FDA for use in neuro-oncology and breast cancer surgery.Cancer · United StatesSee the Story

Breaking News Topics Related to CNIO

Community of Madrid

Community of Madrid

Cancer

Cancer

Spain

Spain

Madrid, Spain

Madrid, Spain

Science

Science

Medical

Medical

News
For You
SearchBlindspotLocal